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Abstract: A femtosecond CARS-based nonlinear optical microscope was 
used to simultaneously image extracellular structural proteins and lipid-rich 
structures within intact aortic tissue obtained from myocardial infarction-
prone  Watanabe  heritable  hyperlipidemic  rabbits  (WHHLMI).  Clear 
differences in the NLO microscopic images were observed between healthy 
arterial  tissue  and  regions  dominated  by  atherosclerotic  lesions.  In  the 
current  ex-vivo  study,  we  present  a  single  parameter  based  on  intensity 
changes derived from multi-channel NLO image to classify plaque burden 
within  the  vessel.  Using  this  parameter  we  were  able  to  differentiate 
between healthy regions of the vessel and regions with plaque, as well as 
distinguish plaques relative to the age of the WHHLMI rabbit. 
©2010 Optical Society of America 
OCIS codes: (170.3880) Medical and biological imaging; (170.4580) Optical diagnostics for 
medicine;  (180.4315)  Nonlinear  microscopy;  (300.6230)  Spectroscopy,  coherent  anti-Stokes 
Raman scattering. 
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1. Introduction 
Atherosclerosis is a chronic progressive disease associated with plaque accumulation in the 
coronary, carotid and peripheral arteries [1–3]. Plaque development once considered to be a 
passive accumulation of lipids and cellular debris is now recognized as part of a complex 
process. Structurally, early disease manifests through a focal thickening of the endothelium 
and  the  formation  of  localized  fatty  streaks  beneath  the  endothelium.  Fatty  streaks  can 
progress to advanced lesions where lipid-laden cells and extracellular lipid droplets form a 
lipid rich necrotic core capped by vascular smooth muscle cells and a collagen-rich fibrous 
network [1,2]. Rupture or erosion of the fibrous cap results in the ejection of the lipid core 
into the vessel resulting in a clot or thrombosis that impedes blood flow in the artery. Imaging 
techniques are relied upon to detect blockages and localize plaques. 
X-ray fluorescence angiography remains an important imaging modality for detecting and 
localizing stenotic lesions in patients [4]. However, 2D x-ray angiography cannot detect non-
stenotic  lesions  making  it  of  little  value  in  quantifying  plaque  burden  or  as  a  tool  for 
understanding  plaque  development.  The  ability  of  multi-detector  computed  tomography 
(MDCT) to detect calcified plaque is well established and preliminary studies suggest that 
MDCT may be able to distinguish between fat and fibrous as well as calcified tissue based on 
CT  density  values  [5].  Coronary  magnetic  resonance  imaging  was  also  reported  in 
classification and quantification of plaque burden, yet its relatively low resolution limits its 
clinical use [6]. Differentiation of plaque type and assessment of plaque burden, in-vivo, so 
far  largely  relies  on  the  use  of  intravascular  ultrasound  (IVUS).  Although  IVUS  allows 
visualization,  in-vivo,  of  the  geometry  of  the  artery  and  atherosclerotic  lesions  [7–9], 
according to histopathological studies it suffers from low specificity and low sensitivity in 
detecting  early  lesions  and  lipid-rich  lesions.  Despite  these  short-comings  IVUS  has 
contributed  significantly  to  our  understanding  of  plaque  development.  Recently  optical 
coherence tomography (OCT) and Raman spectroscopy were also reported to be useful in 
detecting  and  characterizing  atherosclerotic  lesions.  Intravascular  OCT  shows  particular 
promise and several research groups have demonstrated its potential [10–13] by characterizing 
plaque morphology at much higher resolution (~10 µm) than IVUS. Raman spectroscopy is 
ideal  for  identifying  gross  biochemical  changes  in  tissue  and  has  great  potential  to 
discriminate between lipid-rich, calcified and fibrotic plaques [14–18]. It is however a slower 
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develop  methods  to  differentiate  tissue  types  underlines  that  both  morphological  and 
compositional information are crucial for understanding plaque development, plaque burden 
and  predicting  the  risk  of  plaque  rupture  or  erosion.  Despite  these  advances  in  imaging, 
differentiation of types of plaque and assessment of plaque burden can only be verified by 
histological examination that conveys compositional information in a structural context. 
As key structural protein constituents of the extracellular matrix, elastin and collagen are 
the  dominant  biomolecules  associated  with  atherosclerotic  disease  progression.  Similarly, 
modified  cholesterols  as  the  primary  lipid  species  triggering  plaque  development  are 
inextricably linked to the disease. Developing a practical  method capable of interrogating 
these extracellular bio-molecules that are so closely linked to the disease is of great interest to 
many. Recently nonlinear optical (NLO) microscopic imaging has emerged as a powerful tool 
for label-free tissue imaging [19]. It is fast, biochemically specific and possess intrinsic 3-D 
resolution better than confocal microscopy. Two-photon excited fluorescence (TPEF), second-
harmonic generation (SHG) and coherent anti-Stokes Raman scattering (CARS) have been 
intensively  studied  in  imaging  extracellular  elastin,  type-I  collagen  fibrils  and  lipid-rich 
molecules in bulk tissue without preparation or the use of dyes or stains [20–28]. Such label-
free  imaging  capability  renders  NLO  imaging  well  suited  to  understanding  the  role  and 
interplay between these biochemical species in plaque development. In fact, TPEF and SHG 
have  been  used  to  study  arterial  tissue  structures  and  atherosclerotic  lesions  previously  
[29–31]. First label-free NLO imaging of atherosclerotic lesions using three NLO modalities 
(TPEF,  SHG  and  CARS)  was  reported  recently  by  Le  et  al  using  a  multimodal  CARS 
microscope  and  an  Ossabaw  swine  animal  model  of  metabolic  syndrome-induced  arterial 
disease [32]. In this study they visualized CARS signals using two tightly synchronized pico-
second laser beams and another femto-second Ti:sapphire laser for generating TPEF and SHG 
signals.  Based  on  a  similar  optical  setup  and  animal  model,  Wang  et  al.  [33]  also 
demonstrated  quantitative  measurements  of  collagen  and  lipids  contents  in  atherosclerotic 
lesions on thin histological sections using a multimodal NLO microscope. Previously we have 
also demonstrated label-free atherosclerotic tissue imaging using a femtosecond CARS-based 
multimodal  NLO  microscope  developed  earlier  [34]  and  myocardial  infarction-prone 
Watanabe heritable hyperlipidemic (WHHLMI) rabbit strain [35]. The current study develops 
a quantitative metric based on the NLO images obtained from arterial tissue of WHHLMI 
rabbits  and  explores  how  this  metric  could  be  used  to  study  the  mechanisms  of  plaque 
development and quantify plaque burden. All  measurements are performed on intact bulk 
tissue  using  backscattering  detection  (or  Epi-)  mode  for  its  practicality  for  in  vivo 
measurements. Endoscopic TPEF/SHG based on 2-D raster scanning and radial scanning were 
both reported in the literature [36,37]. Although endoscopic CARS has not been realized thus 
far due to challenges in dual laser-pulse delivery in the same optical fiber, progress in this 
direction was reported recently [38]. Thus, it is believed that with the fast advancement of 
new laser sources and nonlinear optical fiber, endoscopic multi-modal CARS could become a 
reality  in  the  not  too  distant  future.  In  this  ex-vivo  study  we  define  an  intensity  based 
summary  parameter  from  multimodal  NLO  images  which  correlates  with  atherosclerotic 
plaque  burden  in  the  WHHLMI  rabbit  model.  This  parameter  also  shows  a  marked 
dependence  on  the  age  of  the  animal.  This  dependence  is  consistent  with  the  expected 
temporal pattern of plaque accumulation within the aorta of these rabbits. 
Multimodal NLO imaging is capable of rapidly surveying bulk arterial tissue and can 
display information with respect to key biochemical components and structures that portend 
advanced  atherosclerosis  in  the  WHHLMI  model.  Along  with  this  visual  representation 
through TPEF, SHG and CARS images, simple intensity based parameters summarizing the 
images can be devised that correlate with disease burden and could be used to further quantify 
disease progression. Given the differences between human disease and the plaques developed 
by  the  WHHLMI  model,  this  index  is  unlikely  to  be  a  good  predictor  of  human  plaque 
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predictive  of  human  plaque  composition  and  morphology  from  NLO  imaging  of  human 
vessels. 
2. Experimental 
2.1. Animal model and tissue preparation 
This study was approved by the local animal care committee at Institute for Biodiagnostics, 
National  Research  Council  Canada.  In  this  study,  myocardial  infarction  prone  Watanabe 
heritable hyperlipidemic rabbits, designated as WHHLMI rabbits [39,40], were used as an 
animal model to mimic spontaneous myocardial infarction in humans. Due to a hereditary 
defect  in  LDL  processing,  WHHLMI  rabbits  develop  atherosclerotic  plaques  without 
requiring a modified diet. Four WHHLMI rabbits 4, 16, 17 and 24 months old, respectively, 
representing various stages of atherosclerotic disease progression were studied with the 24 
months-old rabbit being considered to be nearing the end of its life cycle. 
The  three  older  rabbits  used  in  the  study  were  born  and  raised  in  the  Institute  for 
Experimental Animals, Kobe University, School of Medicine (Kobe, Japan) until they were at 
almost 12 months of age. These rabbits were later transported from Kobe University (Kobe, 
Japan) to the Institute for Biodiagnostics, National Research Council Canada (NRC-IBD). The 
younger rabbit used in the study was born at NRC-IBD. 
The aorta was dissected from the ascending aorta to the external iliac artery and then 
rinsed in heparinized saline. The exterior aorta was delicately cleaned of connective tissue 
prior to being subdivided into ~20-30 mm sections resulting in 5-7 pieces. Additionally, some 
short  segments  were  set  aside  for  histology  at  this  point.  Each  section  was  cut  open 
longitudinally exposing the luminal surface. The samples were placed in petri-dishes with the 
luminal surface facing up on a moist surface and hydration was maintained throughout the 
measurements by periodically applying phosphate buffered saline (PBS) solution to the tissue. 
Digital photos of the luminal surface were acquired and regions of interest were identified 
prior to measurements. 
For histology, the artery was cross-sectioned on a cryotome into sections 8µm in thickness 
while  embedded  in  OCT  (optical  cutting  temperature)  cutting  medium.  Adjacent  artery 
sections were used in multimodal CARS imaging, H&E (hematoxylin and eosin) staining to 
reveal general tissue morphology, picro-sirius red staining for highlighting collagen, and oil 
red O staining for accenting lipid content. The tissue sections prepared for CARS imaging 
received no further treatment after cutting while those prepared for histology were immersion-
fixed in either 95% ethanol or 10% buffered formalin based on individual staining protocols. 
In  visualizing  collagen,  cross-handed  circularly-polarized  microscopy  was  employed  to 
provide higher contrast [41]. Histology images were obtained using a 10x air objective lens on 
a Zeiss Axio Observer Z1 system equipped with AxioCam ICc3 CCD camera (Carl Zeiss 
Canada, Toronto, ON, Canada). 
2.2. Femtosecond CARS-based multimodal NLO microscopic imaging 
A home-built multimodal nonlinear optical (NLO) laser scanning microscope illustrated in 
Fig. 1 was used for TPEF, SHG and CARS imaging of arterial tissues and was described 
previously [35]. The light source for TPEF and SHG imaging was a Ti:Sapphire oscillator 
(Tsunami, Spectra-Physics) centered at 800 nm with a 100 fs pulse duration and a 20 nm 
bandwidth. Average output power was measured at 1W when the oscillator was pumped with 
a  7.25  W  green  laser  at  532  nm  (Millennium  Pro,  Spectra-Physics).  A  Faraday  isolator 
(Newport) was placed close to the emission exit of the Ti:Sapphire oscillator to prevent any 
back reflections of the femto-second pulses from re-entering the laser cavity. Re-compression 
of the pulses was accomplished using a pair of GTI laser mirrors (Layertec GmbH, Germany) 
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Faraday isolator and other microscope optics. 
The femto-second pulse was then split into two beams using a 50:50 beam splitter. The 
reflected pulses were used as the pump beam for CARS imaging and also as the light source 
for TPEF and SHG imaging. Approximately 300mW transmitted pulse after the beam splitter 
was coupled into a PCF (NL-1.4.775-945, NKT Photonics  A/S, Denmark) through a 20x 
objective lens (Newport) generating a broadband emission both in the visible and in the near 
infrared (NIR). The NIR portion (>900nm) of this broadband emission was used as the Stokes 
beam for CARS imaging. The pump and Stokes pulses were combined at a beam combiner 
before  proceeding  into  the  laser  scanning  microscope  assembly.  A  20x,  0.75  NA  infinity 
corrected  air  objective  lens  (Olympus  Canada,  Markham,  ON,  Canada)  focused  the  laser 
pulses on samples and also collected the epi-TPEF/SHG/CARS signals. The collected NLO 
signals were transmitted to three non-descanned PMT detectors (H9656 series, Hamamatsu, 
Bridgewater, NJ, USA) mounted on the microscope assembly for simultaneous TPEF, SHG 
and CARS imaging at 530 ± 20nm, 400 ± 30nm and 630 ± 30nm, respectively. Typically 
25mW of pump and 8mW of Stokes (measured after the 20x air objective lens) were used for 
imaging. 
ScanImage (ver. 3.5) software [42] was used for image acquisition and laser scanning 
control. Pixel dwell time for an average of 4 scans for a single collection was 21 µs. Post 
image  viewing  and  3  channels  separation  were  performed  in  ImageJ  ver  1.42b.  Image 
background correction, intensity normalization and calculation of various image parameters 
were carried out using Matlab. 
 
 
Fig. 1. Schematic of the home-built multimodal nonlinear optical laser scanning microscope. 
Light  source  for  TPEF  and  SHG  imaging  is  a  Ti:Sapphire  femto-second  oscillator 
(Tsunami,Spectra-Physics). For CARS imaging, Stokes pulses are generated in PCF which is 
pumped by the same Ti:sapphire laser. Inset shows a typical video image of a tissue sample 
with lumen surface facing up. F-ISO: Faraday isolator; CM: chirp laser mirrors; BS: beam 
splitter; NIR-F: near-IR filter;; GS: galvo scanner; DM: dichroic mirror; OBJ: objective lens; 
BF: bandpass filter; NDF: neutral density filter; λ/2: half waveplate. 
3. Results and discussion 
3.1. Validating multimodal CARS imaging with histology 
Three different types of histological stains were compared with the multimodal CARS image 
of an adjacent unstained artery section in Fig. 2. Figure 2A, 2B and 2C illustrate H&E (bright 
field), picro-sirius red (circularly polarized light) and oil red O (bright field) stains of adjacent 
artery sections, respectively, to help visualize general tissue morphology and particular extra-
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development, extra-cellular elastin in tunica media, collagen fibrils in tunica adventitia, on 
intima-media boundary and forming the cap on the atherosclerotic plaque as well as lipids in 
plaque bodies are all correctly visualized in a multimodal CARS image with elastin fiber 
color-coded in green (TPEF), collagen fibrils in blue (SHG) and lipids in red (CARS) (shown 
in Fig. 2D). The correspondence between the histological sections and the multimodal CARS 
images validates our understanding of what gives rise to contrast in the multimodal CARS 
image.  This  validation  ensures  accurate  interpretation  of  multimodal  CARS  imaging  in 













Fig. 2. Comparison of (A) H&E (B) picro-sirius red (C) oil red O histological stain with (D) 
label-free multimodal CARS image of adjacent artery cross-sections. Color-codes shown in 
(D): green is TPEF representing mainly elastin, blue is SHG representing mainly collagen 
fibrils and red is CARS representing mainly lipids content. Both SHG and CARS signals are 
collected in the forward-direction while TPEF is collected in the backscattered (epi-) direction. 
3.2. Scoring and image evaluation 
Collagen fibril scoring was previously developed using parameters extracted from collagen 
SHG  images,  according  to  Strupler  et.  al.  [43].  In  that  work  the  authors  used  three 
phenomenological  scores,  D,  S,  and  SF  to  quantify  the  distribution  and  morphology  of 
collagen fibrils in unlabeled fibrotic murine kidney tissue sections using SHG images, where 
D (density) is the volume density of pixels exhibiting a significant SHG signal; S (signal) is 
the average value of the SHG signal in a corrected SHG image and SF (signal in fibers) is the 
ratio of the other two scores: SF = S/D representing average SHG signal intensity in regions 
exhibiting significant SHG signals. 
This method worked well in scoring collagen in sectioned kidney tissue but may prove 
challenging in classifying complex biological structures such as atherosclerotic lesions using 
multi-dimensional  information  (SHG  for  collagen,  TPEF  for  elastin  and  other  fluorescent 
particles and CARS for lipid-rich structure) derived from a bulk tissue due to pathological 
interplay  of  extracellular  components  in  an  atherosclerotic  lesion.  In  order  to  address  the 
complexity and the dynamic nature of atherosclerotic disease progression, we developed a 
new parameter that can accurately track plaque burden in the vessel using biochemical data 
collected through combined elastin, collagen and lipid imaging. 
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images,  three  SF  scores  were  extracted  from  individual  SHG,  CARS  and  TPEF,  but  co-
registered, images of the same sample. Parameters D and S were calculated for all TPEF, 
SHG and CARS images using definitions given by Stupler et al. [43]. Note that Strupler et al 
define S/D as a signal in fibres score (SF), but in this study we are using a more generic term, 
called significant signal score (SS), since not all three imaging channels (SHG, CARS and 
TPEF), represent biomolecules that have fibrous structures. A significant signal score (SS) 
was calculated for each image using the equation SS = S/D. 
Each individual image (SHG, CARS or TPEF) was first corrected for PMT dark signals 
and for the PMT amplification level used in different channels by normalizing the whole 
image to a pre-determined PMT amplification curve. Three SS scores (SSSHG, SSCARS and 
SSTPEF) were calculated using the corrected SHG, CARS and TPEF images collected over the 
same sampling location. 
3.3. Significant signal score (SS) – correlation with rabbits’ age 
In  order  to  calculate  the  significant  signal  score  (SS),  multimodal  epi-NLO  images  were 
acquired from smooth/healthy luminal surface and atherosclerotic plaques of four WHHLMI 
rabbits of different ages, 4, 16, 18, and 24 months-old, respectively. 
In  Fig.  3  some  examples  of  how  those  regions  looks  under  our  multimodal  NLO 
microscope. Figure 3A was acquired at a healthy region of the arterial lumen of a 4 months-
old rabbit, while Figs. 3C, 3E and 3G were acquired from healthy lumen of the 16, 18, and 24 
months-old rabbits, respectively. The images in Fig. 3B, 3D, 3F, and 3H were acquired from 
atherosclerotic plaques found in rabbits of 16, 18, and 24 months-old, respectively. The co-
localized  TPEF/CARS/SHG  images  acquired  by  three  separate  detection  channels  of  the 
microscope  are  represented  by  different  colors  where  TPEF  signal  is  presented  in  green, 
CARS signal is presented in red and SHG signal is presented in blue. 
 
Fig.  3.  Representative  multimodal  epi-NLO  image  acquired  from  smooth/healthy  luminal 
surface of the WHHLMI rabbit artery, that is (A) 4 months-old, (C) 16 months-old, (E) 18 
months-old, (G) 24 months-old, and atherosclerotic plaques found on the WHHLMI rabbit 
arteries at (B) 4 months-old, (D) 16 months-old, (F) 18 months-old, and (H) 24 months-old. 
(20x air objective lens, 0.75 NA). 
In  a  representative  NLO  image  of  a  healthy  lumen,  Fig.  3A,  only  the  luminal  elastic 
lamina is clearly visible from the TPEF signal and neither lipid-rich structures nor collagen 
fibrils in the CARS and SHG signals are evident. On the contrary, Fig. 3H, a representative 
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structures  (CARS  in  red),  collagen  fibrils  (SHG  in  blue)  along  with  strongly  fluorescent 
(TPEF in green) macromolecules differing in structure from the luminal elastic lamina that 
dominate the images of healthy vessels illustrated in Fig. 3A. The enhanced SHG intensity 
arising from collagen fibrils and the CARS intensity arising from lipid-rich structures, from 
regions of plaque (see Fig. 3B, 3D, 3F and 3H) are consistent with known plaque pathology 
and explain the increased SSSHG and SSCARS  scores from  regions of plaque; however, the 
SSTPEF score shows no obvious difference between regions of plaque and healthy vessel. The 
diminishing  elastin  content  at  the  region  of  plaque  is  compensated  for  by  an  increasing 
number of other fluorescent macromolecules detected by TPEF. 
In order to better illustrate the change in SS scores with respect to plaque progression 
represented by the age of the rabbit, the mean SS scores obtained from the images of four 
rabbits (4, 16, 18, and 24 months-old) are presented in Fig. 4. 
 
Fig. 4. Comparison of the SS scores extracted from SHG, CARS and TPEF images acquired 
from the arterial lumen of four WHHLMI rabbits: 4 months-old, 16 months-old, 18 months-old 
and 24 months-old. 
The mean SS scores and their standard deviations were obtained by averaging over all SS 
scores extracted from all of the measurement locations including healthy and atherosclerotic 
luminal surfaces, along the same artery of the same animal. A total of 31, 29, 38 and 40 
different locations were measured for the 4 months-old, 16 months-old, 18 months-old, and 24 
months-old rabbit, respectively, resulting in approximately 800 processed images. 
According to the data presented in Fig. 4, it is clear that it is not possible to differentiate 
atherosclerotic plaque burden using any of the SS scores as there is no evident correlation. In 
principle when atherosclerotic plaques become worse, it should lead to an increase of SHG 
and CARS signals as both collagen and lipids content increase; however, SSSHG and SSCARS 
scores  are  not  increasing  proportional  to  plaque  development:  the  SSSHG  score  for  the 
youngest rabbit (4 months-old) is 1.8 ± 2.6 and for the oldest one (24 months-old) it is 2.1 ± 
3.0  Considering  the  spread  of  the  scores  as  evident  from  the  standard  deviations  of  both 
values, it can be concluded that these values are not statistically significant different, therefore 
SS scores alone is not a good parameter to use to differentiate plaque burden. 
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As discussed in previous sections, the mean SS scores generally are well correlated in scoring 
collagen  in  sectioned  kidney  tissue,  but  they  are  not  reliable  indicators  for  distinguishing 
atherosclerotic plaques. For instance, some NLO images taken from advanced plaques are 
abundant  in  lipid-rich  structures  but  show  no  collagen  fibrils  (e.g.  lipid-rich  type-IV 
atheroma). Others  show a  high density of collagen  fibrils along  with abundant  lipid (e.g. 
collagenous type-Va fibrous atheroma). Although both lesion types are considered advanced, 
the lower SSSHG score derived from a type IV atheroma might underestimate disease severity. 
We propose a new optical index for plaque burden, or OIPB index. 
Considering the images presented in Fig. 5, which are organized based on the level of 
plaque burden, it is possible for us to define some patterns of changes in all three NLO signal 
channels.  Figure  5A–5C  show  examples  of  healthy  arterial  lumen;  Fig.  5D  shows  an 
atherosclerotic lesion found in a young rabbit artery; Fig. 5E is an atherosclerotic plaque, 
where  it  is  possible  to  note  some  collagen  fibers  formation  (shown  blue);  Fig.  5F  is  an 
atherosclerotic plaque with higher lipid (shown red) content; Fig. 5G is an atherosclerotic 
plaque containing a high density of collagen fibers and lipids, and finally Fig. 5H is a very 
advanced plaque. 
 
Fig.  5.  Representative  multimodal  epi-NLO  image  acquired  from  the  luminal  surface  of 
WHHLMI rabbit arteries, with (A) -(C) healthy lumen; (D) early atherosclerotic plaque found 
in  young  rabbit;  (E)  atherosclerotic  plaque  (with  dense  collagen  fibers  shown  blue);  (F) 
atherosclerotic  plaque  with  higher  lipid  content  shown  red;  (G)  atherosclerotic  plaque 
containing collagen fibers and lipids, and (H) very advanced plaque (20x air objective lens, 
0.75 NA). 
The  three  average  SS  values  for  each  image  shown  in  Fig.  5  are  calculated  and  then 
presented in Fig. 6 where the SSSHG and SSCARS scores are associated with collagen and lipids 
(both are associated with plaque regions), respectively, and SSTPEF scores can be associated 
with elastin in healthy tissue or with other fluorescent macromolecules in the region of plaque. 
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Fig. 6. Average SS scores extracted from SHG (blue squares), CARS (red circles) and TPEF 
(green triangles) images acquired from the arterial lumen of WHHLMI rabbits. Images A-H 
correspond to those shown in Fig. 5 
From  Fig.  6,  we  clearly  observe  a  pattern  for  each  of  the  SS  scores,  which  can  be 
summarized as follows. The healthier the tissue is, the lower the SSSHG and the SSCARS but the 
higher the SSTPEF. The opposite is true if the tissue has an increased burden of plaque. In 
addition, we can also observe a correlation between the differences between the three SS 
scores based on the health of the tissue. For instance, the healthier the tissue is, as the greater 
the difference between SSSHG and SSTPEF, with SSTPEF being higher than SSSHG; and also the 
greater the difference between SSCARS and SSTPEF, with SSTPEF higher than SSCARS. Based on 
these observations, an OIPB index can be defined by the equation, 
  ( ) ( ) ( , ) , , SHG CARS SHG TPEF CARS TPEF CARS SHG OIPB SS SS d SS SS d SS SS d SS SS = + + + +    (1) 
where the terms d(SSX, SSY) are the difference between two SS scores (SHG, CARS and 
TPEF),  d(SSx,  SSy)  =  SSx  -  SSy.  Note  that  SSTPEF  score  alone  was  not  included  in  the 
calculation  of  OIPB  indices  because  it  provides  no  additional  contrast  in  discriminating 
between  atherosclerosis  lesions  from  healthy  vessel  wall  as  mentioned  earlier.  A  term 
d(SSCARS, SSSHG) was added in the calculation for its value in discriminating between a lipid-
rich type-IV atheroma and a type-V fibrous atheroma. OIPB indices were calculated for all 
NLO images and were normalized using the same method described earlier. 
3.5. OIPB index of the arterial lumen as a function of plaque burden 
In order to better illustrate the utility of the OIPB index Fig. 7 plots the mean OIPB index 
obtained  from  images  of  the  lumen  surface  from  healthy  (OIPBhealthy)  and  atherosclerotic 
(OIPBathero) regions for each rabbit presented in the order of the age of the rabbit. In all cases, 
OIPBathero is significantly higher than OIPBhealthy. The OIPB index from regions of plaque 
increase in a linear fashion with the age of the WHHLMI rabbit, representing the overall 
burden of plaque in the aorta. 
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Fig. 7. Mean OIPB indexes of healthy and atherosclerotic lumen surfaces as a function of 
rabbits’ age. 
According to previous studies [39,45,46] and the observation in the current study, young 
WHHLMI rabbits at 4-6 months of age only show lipid streaks on the luminal wall of the 
aorta while most of the lumen surface remains largely intact. At 15-20 months of age, plaque 
has accumulated over large areas of the lumen surface of the aorta of the rabbit. Past 20 
months, almost the entire rabbit artery is covered with advanced lesions with very limited 
intact surface. A strong correlation is observed between the OIPB indices and the burden of 
plaque found in WHHLMI rabbits. Another analysis shows the mean arterial OIPB index for 
each rabbit pooling all the measurements whether from healthy and plaque dominated regions 
of the lumen. This age-based mean OIPB index plotted as a function of the age of the rabbit is 
illustrated in Fig. 8. 
So  far,  we  demonstrated  that  the  OIPB  index  is  a  better  discriminatory  parameter 
compared to the SS scores in differentiating plaque burden. This result also illustrates that 
inter-channel  intensity  changes  detected  among  TPEF,  SHG  and  CARS  correlate  with 
atherosclerotic plaque progression as evident in Fig. 9 which compares the individual OIPB 
index of Fig. 5A–5H. 
To help visualize the correlation between OIPB index, its corresponding NLO image and 
the  age  of  the  animal,  NLO  images  collected  from  various  healthy  areas  of  lumen  and 
atherosclerotic lesions are shown in Fig. 10 along with the respective OIPB index and rabbit’s 
age. 
Figures 10A and 10B show a healthy lumen with a very low OIPB index of −30.8 and - 
23.6, respectively, and Fig. 10C shows an image with an OIPB of 17.7 taken from an early 
lesion (or a fatty streak) found in a 4 months-old rabbit artery. 
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Fig. 8. Mean OIPB indexes of all regions of arterial lumen as a function of rabbits’ age. 
 
Fig. 9. OIPB indices of all images shown in Fig. 5. OIPB index is a better discriminatory 
parameter in differentiating plaque burden. 
The biochemical tissue morphology looks very different between these three images and 
this difference is also reflected in their respective OIPB values. Figures 10D and 10E are 
images of plaques found in the arteries of 16 and 17 months-old rabbits. These lesions are 
more advanced than that shown in Fig. 10C. The OIPB index for the images in Fig. 10D and 
10E are both higher than that of Fig. 10C reflecting the more advanced nature of the plaque. 
Figure 10F shows an image of the surface of a plaque from a 24 months-old rabbit that died of 
natural causes. An OIPB index of 109.1 is calculated from this image which is the highest 
among all those illustrated in Fig. 10. 
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Fig. 10. Representative epi-NLO images obtained from the luminal surface of thoracic aorta of 
rabbits sacrificed at (A), (B) and (C) 4 months (D) 16 months (E) 17 months and (F) 24 months 
of age. Images were collected using 20x air objective lens. These are the sum images of 5 
consecutive image planes taken at 2 µm steps from 20µm to 30µm beneath the luminal surface. 
Green is TPEF signal representing elastin fiber and other endogenous fluorescent molecules; 
Blue is SHG signal representing fibrillar collagen; Red is CARS signal representing lipids-rich 
structures in plaque. 
Correlation  analysis  using  OIPB  indices,  WHHLMI  rabbit  age,  disease  state  and 
biochemical  tissue  morphology  clearly  show  that  younger  rabbits  with  less  plaque 
development  have a lower OIPB index  with the NLO images of healthy lumen generally 
having  a  negative  OIPB  value.  This  negative  OIPB  value  is  a  result  of  the  near-zero 
significant  signal  scores,  SSSHG  and  SSCARS,  along  with  the  negative  values  of  d(SSSHG, 
SSTPEF) and d(SSCARS, SSTPEF) in Eq. (1). As shown in Figs. 3A, 3C, 3E, 3G, 5A, 5B, 5C, 10A 
and 10B, internal elastic membrane and elastin fibers were often the only major extracellular 
component  in  the  images  of  healthy  lumen  thus  resulting  in  near-zero  SSSHG  and  SSCARS 
scores. As atherosclerotic lesions progress, either SSSHG (collagen content) or SSCARS (lipids 
content) or both scores increase, thus leading to higher OIPB values. The last term d(SSCARS, 
SSSHG) in Eq. (1) can help differentiate type V(Va) from type IV atheroma by distinguishing 
the relative intensity difference between SHG (mostly from collagen) and CARS (mostly from 
lipid-rich  structures)  signals.  According  to  the  classification  of  atherosclerotic  lesions 
provided by American Heart Association [44], type IV lesions are characterized by dense 
accumulation  of  extracellular  lipid  while  type  V  display  the  formation  of  prominent  new 
fibrous connective tissue. The d(SSCARS, SSSHG) score is therefore more likely to be higher for 
a type V(Va) lesion than for a type IV lesion due to higher collagen density this in turn will 
result in a higher OIPB index for a type V(Va) atheroma. 
Visual investigation of the NLO images not only show the formation of fibrillar collagen 
and lipid-rich structures on the lumen surface in progressive plaques, but also the texture of 
the collagen fibrils change during the course of lesion development. For example, an image 
acquired  from  an  early  lesion  shows  only  thin  sparse  collagen  fibrils  (Fig.  10C)  but  in 
advanced lesions (Fig. 10E and 10F) the collagen fibrils are thicker and more directional. We 
believe that more detailed texture analysis of fibrillar collagen visualized by SHG could lead 
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based model in quantifying plaque burden from label–free NLO imaging of arteries. 
4. Conclusion 
An intensity-based parameter based on three intrinsic nonlinear optical signals, TPEF, SHG 
and  CARS,  collected  from  images  of  the  lumen  surface  of  the  aorta  from  rabbits  was 
developed that provides a quantitative model for differentiating atherosclerotic plaque burden. 
This new optical index for plaque burden, OIPB, was defined using the NLO images acquired 
from  ex-vivo  samples  of  un-sectioned  bulk  rabbit  arterial  tissue.  This  index  showed  a 
correlation with the age of the WHHLMI rabbits and the severity of the atherosclerotic lesions 
in the rabbits. Additional texture and shape analysis of the collagen fibrils detected in the 
SHG imaging of lesions and a larger number of samples could further improve the reliability 
of the proposed model for the quantification of plaque burden in the WHHLMI model. Given 
that human plaque development goes through stages of development involving the same key 
biochemical  building  blocks  that  can  be  sensitively  detected  by  NLO  imaging,  this  work 
suggests that a similar strategy could be used to develop objective measures to classify human 
disease based on NLO imaging. 
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